Hypotension from afatinib in epidermal growth factor receptor-mutated non-small cell lung cancer: a case report and literature review

被引：2
|
作者：
Tang, Zhiwei [1 ]
Ji, XiuHai [2 ]
Zhou, Guanghui [1 ]
Chen, Ruhua [1 ]
Fen, Yan [1 ]
Ding, Hui [1 ]
机构：
[1] Jiangsu Univ, Affiliated Yixing Peoples Hosp, Dept Pulm & Crit Care Med, Yixing, Peoples R China
[2] Affiliated Taicang Hosp Tradit Chinese Med, Dept Oncol, Taicang, Peoples R China
来源：
ANTI-CANCER DRUGS | 2022年 / 33卷 / 01期
关键词：
afatinib; epidermal growth factor receptor; hypotension; lung cancer;
D O I：
10.1097/CAD.0000000000001244
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Side effects of afatinib are a problem in patients with advanced non-small cell lung cancer (NSCLC). However, little is known about the occurrence of afatinib-induced hypotension. An 81-year-old man with NSCLC had an epidermal growth factor receptor-positive genotype with the p.L861Q mutation in exon 21. He was administered afatinib (40 mg/day) as anticancer therapy. Hypotension occurred twice after afatinib initiation. He suffered from dizziness and nausea. Blood pressure gradually returned to normal after afatinib cessation. Clinicians should be aware of hypotension in patients with NSCLC after afatinib initiation.
引用
收藏
页码：E840 / E841
页数：2
相关论文
共 50 条
  • [21] Histologic transformation of epidermal growth factor receptor-mutated lung cancer
    Fujimoto, Daichi
    Akamatsu, Hiroaki
    Morimoto, Takeshi
    Wakuda, Kazushige
    Sato, Yuki
    Kawa, Yoshitaka
    Yokoyama, Toshihide
    Tamiya, Motohiro
    Hiraoka, Ryota
    Shingu, Naoki
    Ikeda, Hideki
    Tamiya, Akihiro
    Kanazu, Masaki
    Miyauchi, Eisaku
    Miura, Satoru
    Yanai, Masaaki
    Yomota, Makiko
    Morinaga, Ryotaro
    Yokoi, Takashi
    Hata, Akito
    Suzuki, Hidekazu
    Matsumoto, Hirotaka
    Sakata, Shinya
    Furuya, Naoki
    Harutani, Yuhei
    Nakachi, Ichiro
    Otsuki, Ayumu
    Uematsu, Shinya
    Hara, Satoshi
    Yokoo, Keiki
    Sugimoto, Takeya
    Yamamoto, Nobuyuki
    EUROPEAN JOURNAL OF CANCER, 2022, 166 : 41 - 50
  • [22] Sequential chemotherapy and icotinib as first-line treatment for advanced epidermal growth factor receptor-mutated non-small cell lung cancer
    Sheng-Jie Sun
    Jin-Di Han
    Wei Liu
    Zhi-Yong Wu
    Xiao Zhao
    Xiang Yan
    Shun-Chang Jiao
    Jian Fang
    World Journal of Clinical Cases, 2022, 10 (18) : 6069 - 6081
  • [23] Moving osimertinib to first-line: the right "strategy" in the chessboard of epidermal growth factor receptor-mutated non-small cell lung cancer?
    Passiglia, Francesco
    Raez, Luis E.
    Rolfo, Christian
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S1076 - S1080
  • [24] A Case of Epidermal Growth Factor Receptor-Mutated Non-Small-Cell Lung Cancer: Multi-Line Treatment and Resistance Mechanisms
    Teixeira, Ana Raquel
    Fernandes, Rute
    Rodrigues, Ana
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (01)
  • [25] Epidermal growth factor receptor in non-small cell lung cancer
    Prabhakar, Charles N.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2015, 4 (02) : 110 - 118
  • [26] Genetic polymorphisms of the epidermal growth factor and related receptor in non-small cell lung cancer -: A review of the literature
    Araujo, Antonio
    Ribeiro, Ricardo
    Azevedo, Isabel
    Coelho, Ana
    Soares, Marta
    Sousa, Berta
    Pinto, Daniela
    Lopes, Carlos
    Medeiros, Rui
    Scagliotti, Giorgio V.
    ONCOLOGIST, 2007, 12 (02): : 201 - 210
  • [27] Efficacy of osimertinib in epidermal growth factor receptor-mutated non-small-cell lung cancer patients with pleural effusion
    Hiroshi Nokihara
    Hirokazu Ogino
    Atsushi Mitsuhashi
    Kensuke Kondo
    Ei Ogawa
    Ryohiko Ozaki
    Yohei Yabuki
    Hiroto Yoneda
    Kenji Otsuka
    Yasuhiko Nishioka
    BMC Cancer, 22
  • [28] Efficacy of osimertinib in epidermal growth factor receptor-mutated non-small-cell lung cancer patients with pleural effusion
    Nokihara, Hiroshi
    Ogino, Hirokazu
    Mitsuhashi, Atsushi
    Kondo, Kensuke
    Ogawa, Ei
    Ozaki, Ryohiko
    Yabuki, Yohei
    Yoneda, Hiroto
    Otsuka, Kenji
    Nishioka, Yasuhiko
    BMC CANCER, 2022, 22 (01)
  • [29] Small-cell lung cancer with epidermal growth factor receptor mutation: Case report and review of literature
    Asai, N.
    Ohkuni, Y.
    Matsuda, M.
    Kaneko, N.
    INDIAN JOURNAL OF CANCER, 2014, 51 (03) : 384 - U266
  • [30] Factors associated with prolonged progression-free survival of patients treated with first-line afatinib for advanced epidermal growth factor receptor-mutated non-small cell lung cancer
    Chiu, Li-Chung
    Hsu, Ping-Chih
    Wang, Chin-Chou
    Ko, How-Wen
    Kuo, Scott Chih-Hsi
    Ju, Jia-Shiuan
    Tung, Pi-Hung
    Huang, Allen Chung-Cheng
    Yang, Cheng-Ta
    THORACIC CANCER, 2024, 15 (07) : 529 - 537
12345